2012 ACR/ARHP Annual Meeting

November 9-14, 2012. Washington, DC.

View by Title View Sessions

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Abstract Number: 1355

Hand Bone Loss Is Arrested in Early Psoriatic Arthritis but Not in Rheumatoid Arthritis Following Anti-Rheumatic Treatment Assessed by Digital X-Ray Radiogrammetry
Abstract Number: 967

Haplotypes of GTP Cyclophydrolase Gene Polymorphisms Are Protective in the Susceptibility of Fibromyalgia Syndrome
Abstract Number: 1086

Has the Level of Disability At Time of TKR Changed Over the Past 10 Years?: Results From Two National Cohorts
Abstract Number: 2449

Head to Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
Abstract Number: 622

Headache in Systemic Lupus Erythematosus (SLE): Results From a Prospective, International, Inception Cohort Study
Abstract Number: 931

Health Care Utilization Among Medicaid Enrollees with Systemic Lupus Erythematosus Preceding the Development of End-Stage Renal Disease: Sociodemographic Variation
Abstract Number: 93

Health State Utilities in Systemic Sclerosis: Results From the UCLA Scleroderma Quality of Life Study
Abstract Number: 1394

Health Status Burden and Impact of Fatigue On Patient Functioning in SLE Patients From a Phase 1b Study
Abstract Number: 2427

Health-Related Quality of Life in Adolescents with Rheumatic Disease
Abstract Number: 1833

Healthcare Costs in Psoriatic Arthritis Patients Newly Initiated On a Biologic Disease-Modifying Anti-Rheumatic Drug or Methotrexate
Abstract Number: 1502

Hedgehog Signaling in Murine Chronic Sclerodermatous Graft-Versus-Host Disease
Abstract Number: 1250

Heightened Aortic Wall Inflammation in Patients with Rheumatoid Arthritis Versus Patients with Established Coronary Artery Disease without Autoimmune Disease
Abstract Number: 2484

Hepatic Steatosis in Rheumatoid Arthritis: Associations with Disease Characteristics, Pharmacotherapies, and Atherosclerosis
Abstract Number: 2490

Herpes Zoster and Tofacitinib Therapy in Patients with Rheumatoid Arthritis
Abstract Number: 1519

Heterogeneous Nuclear RNP-K Is a Novel Cold-Related Autoantigen in Patients with Raynaud’s Phenomenon
Abstract Number: 1330

High Body Mass Index Is Associated with Decreased Response to Initial Combination Therapy in Recent Onset RA Patients
Abstract Number: 1031

High Degree of Symmetricity of MRI-Detected Articular Tissue Damage in Subjects with Knee Pain: A within-Person Analysis From the JOG Study
Abstract Number: L2

High Dose Immunoablation and Autologous Hematopoietic Stem Cell Transplantation Versus Monthly Intravenous Pulse Therapy Cyclophosphamide in Severe Systemic Sclerosis
Abstract Number: 1203

High Expression of Genes in the Toll-Like Receptor and Interferon Pathways Are Associated with Radiographic Damage in African-Americans with ACPA-Positive RA
Abstract Number: 2380

High Frequency of Ferritin Autoantibodies in Takayasu Arteritis
Abstract Number: 1256

High Inflammation May Condition the Antiatherogenic Function of Small, Dense HDL in Patients with Active Rheumatoid Arthritis
Abstract Number: 2089

High Local Cathepsin Activity in a Murine Rheumatoid Arthritis Model, but Not in an Osteoarthritis Model, Explains the Difference in Cartilage Vdipen Neoepitope Formation
Abstract Number: 2393

High Mobility Group Box 1 Levels Are Not Associated with Subclinical Carotid Atherosclerosis in Patients with Granulomatosis with Polyangiitis but Are Reduced by Glucocorticoids and Statins
Abstract Number: 400

High Patient Global Assessment Scores Associate with the Residual Disease Activity Unidentified by a 28-Joint Examination in Rheumatoid Arthritis Patients Approaching Clinical Remission
Abstract Number: 223

High Prevalence and Clustering Over Time of Anti-PL-7 Autoantibody-Positive Idiopathic Inflammatory Myopathies
Abstract Number: 586

High Prevalence of Anti-CD-74 Antibodies with Specificity for the Class II-Associated Invariant Chain Peptide in Patients with Axial Spondyloarthritis but Not in Controls
Abstract Number: 2026

High Prevalence of Cervical Spine and Temporomandibular Joint Involvement in Patients with Juvenile Idiopathic Arthritis
Abstract Number: 201

High Rate of Autoimmune Manifestations During Idiopathic CD4 Lymphocytopenia
Abstract Number: 2179

High Resolution CT Findings and Concomitant Nontuberculosis Mycobacterial Infection (NTM) in Patients with the Diagnosis of Primary Sjogren’s Syndrome Evaluated At a Respiratory Referral Center
Abstract Number: 1007

High Resolution Peripheral Quantitative CT Detects Marked Differences in Metacarpal Head and Shaft and Ultra-Ultra-Distal Radius Bone Volumetric Density and Microstructure in Early Rheumatoid Arthritis
Abstract Number: 2541

High Risk of Intensive Care Unit Admission in Rheumatoid Arthritis Patients: A Population Based Study
Abstract Number: 2251

High Sensitivity C-Reactive Protein, Disease Activity and Cardiovascular Risk Factors in Systemic Lupus Erythematosus
Abstract Number: 964

High-Energy Extracorporeal Shock Wave Therapy Is Effective for Treating Chronic Calcific Tendonitis of the Shoulder: A Meta-Analysis
Abstract Number: 1651

Higher Corticosteroid Doses Early in Disease Have A Long-Term Influence On Metabolic Syndrome in Systemic Lupus Erythematosus: Data from an International Inception Cohort
Abstract Number: 2396

Higher Homocysteine Levels Are Associated with Ischemic Arterial Events Rather Than Disease Activity and the Extension of Arterial Involvement in Takayasu Arteritis
Abstract Number: 708

Histological Features of Localized Scleroderma‘en Coup De Sabre‘: A Study of 16 Cases
Abstract Number: 2553

Histological, Serological and Clinical Changes in Response to Abatacept Treatment of Sjögren’s Syndrome
Abstract Number: 1444

HLA-DR3 Controls Autoantibody Response to Sm in NZM2328.DR3+.AE0 Transgenic Mice
Abstract Number: 1937

HLA-DRB1*0101/*0405 Is Associated with Susceptibility to Anti-MDA5 Antibody-Positive Dermatomyositis in the Japanese Population
Abstract Number: 2400

Hospital for Special Surgery Osteoarthritis Wellness Initiative: the Impact of a Hospital-Based Exercise Program On Osteoarthritis
Abstract Number: 1387

Hospitalizations and Reasons for Admission in a Clinical SLE Cohort
Abstract Number: 283

Hospitalizations for Patients with Chilhood-Onset Systemic Lupus Erythematosus in the Pediatric Health Information System Databse
Abstract Number: 938

Hospitalizations in Systemic Lupus Erythematosus: A Longitudinal Study
Abstract Number: 2543

Hospitalized Bacterial Infections Among U.S. Veterans with Rheumatoid Arthritis Initiating TNF Antagonist and Newer Biologic Agents
Abstract Number: 1578

How Disease Activity Trajectories Affect the Willingness to Change Treatment
Abstract Number: 1565

How FMS Patients Become Workaholics
Abstract Number: 2235

How Important Is the Assessment of ASDAS in the Long-Term Evaluation of Disease Activity in Ankylosing Spondylitis? A Comparison with Currently Used Clinical Parameters
Abstract Number: 794

How Many Steps/Day Are Associated with a Community Level Gait Speed Among Older Adults with or At High Risk of Knee OA?
Abstract Number: 2101

How Much Can Patient Reported Outcomes Improve Among Rheumatoid Arthritis Patients Who Have a Clinical Response to Biologic Therapy but Have Not Attained Low Disease Activity?
Abstract Number: 2212

How Much Does the Spondyloarthritis Research Consortium of Canada Score of the Sacroiliac Joints Change Over a 3-Month Period in Patients On Non-Biological Treatment?
Abstract Number: 98

How to Assess Risks for Pulmonary Infection in Patients Receiving Immunosuppressive Treatment for Rheumatic Diseases? A Report From a Large-Scale Prospective Cohort Study
Abstract Number: 2188

How to Better Define Inclusion Criteria in a Large Controlled Trial in Primary Sjogren Syndrome ?
Abstract Number: 2207

How Useful Is Imaging of the Sacroiliac Joints (MRI and/or X-ray) in Patients with Possible Spondyloarthritis in the Diagnostic Work-up?
Abstract Number: 1306

How well Do Patients with Rheumatoid and Psoriatic Arthritis Tolerate Methotrexate? A Retrospective Review of Discontinuation Data From a Large UK Cohort
Abstract Number: 2345

HRES-1/RAB4-Mediated Loss of DRP1 Inhibits Mitophagy, Promotes Accumulation of Mitochondria and Serves As Target for Treatment in SLE
Abstract Number: 50

Human Chondrocyte Dedifferentiation Is Accompagnied by CD105 Endoglin Expression, ALK-1/Smad1/5 Phosphorylation and Leptin Production – Stimulation by Prednisolone and Aldosterone Through the Glucocorticoid Receptor
Abstract Number: 1820

Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Gardasil^®) and Autoimmune Disorders: Safety Assessment Using the Pharmacoepidemiologic General Research Extension System
Abstract Number: 230

Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCoR) Antibody in Necrotizing Myopathy and the Role of Statins
Abstract Number: 2482

Hydroxychloroquine Has Lipid-Lowering Effects in US Veterans with Rheumatoid Arthritis
Abstract Number: 1260

Hydroxychloroquine Reduces the Risk of Coronary Artery Disease in Patients with Rheumatoid Arthritis
Abstract Number: 2569

Hydroxychloroquine Reduces Thrombosis in Systemic Lupus Erythematosus, Particularly in Antiphospholipid Positive Patients
Abstract Number: 2268

Hyperacetylation of Histone H4 in Systemic Lupus Erythematosus
Abstract Number: 1773

Hyperammaglobulinemia in Primary Sjögren’s Syndrome Is Induced by Triggering of TLR7 and 9
Abstract Number: 2528

Hypertrophic Pachymeningitis: IgG4-Related Disease Is A Common Etiology
Abstract Number: 1858

Hypervigiliance in Fibromyalgia
Abstract Number: 2262

Hypogammaglobulinemia in Pediatric Systemic Lupus Erythematosus
Abstract Number: 1967

Hypophosphatemic Osteomalacia Induced by Tenofovir in Patients with Human Immunodeficiency Virus Infection
Abstract Number: 415

Hypoxia-Induced Endogenous Prostaglandin E2 Negatively Regulates Hypoxia-Enhanced Aberrant Overgrowth of Rheumatoid Synovial Tissue
Abstract Number: 1065

Hypoxia-Inducible Factor-1α: Trigger of Toll-Like Receptor Signalling-Engaged Inflammation in Rheumatoid Arthritis

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].